At close: 4:08:20 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
386.000
386.000
538.000
5,067.000
Operating Expense
365,059.000
365,059.000
364,990.000
215,532.000
Operating Income
-364,673.000
-364,673.000
-364,452.000
-210,465.000
Net Non Operating Interest Income Expense
9,275.000
9,275.000
8,718.000
749.000
Pretax Income
-379,459.000
-379,459.000
-402,894.000
-732,949.000
Net Income Common Stockholders
-379,459.000
-379,459.000
-402,894.000
-732,949.000
Diluted NI Available to Com Stockholders
-379,459.000
-379,459.000
-402,894.000
-732,949.000
Basic EPS
-1.05
-1.05
-1.08
-1.96
Diluted EPS
-1.05
-1.05
-1.08
-1.96
Basic Average Shares
361,810.000
361,810.000
373,239.895
373,239.895
Diluted Average Shares
361,810.000
361,810.000
373,239.895
373,239.895
Total Expenses
365,059.000
365,059.000
364,990.000
215,532.000
Net Income from Continuing & Discontinued Operation
-379,459.000
-379,459.000
-402,894.000
-732,949.000
Normalized Income
-355,244.000
-355,244.000
-385,170.000
-730,381.000
Interest Income
10,799.000
10,799.000
9,505.000
1,640.000
Interest Expense
1,524.000
1,524.000
787.000
891.000
Net Interest Income
9,275.000
9,275.000
8,718.000
749.000
EBIT
-377,935.000
-377,935.000
-402,107.000
-732,058.000
EBITDA
-355,352.000
-355,352.000
-384,490.000
-718,882.000
Reconciled Depreciation
22,583.000
22,583.000
17,617.000
13,176.000
Net Income from Continuing Operation Net Minority Interest
-379,459.000
-379,459.000
-402,894.000
-732,949.000
Total Unusual Items Excluding Goodwill
-24,215.000
-24,215.000
-17,724.000
-2,568.000
Total Unusual Items
-24,215.000
-24,215.000
-17,724.000
-2,568.000
Normalized EBITDA
-331,137.000
-331,137.000
-366,766.000
-716,314.000
12/31/2021 - 9/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9969.HK InnoCare Pharma Limited
6.150
-0.32%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
64.64
-4.36%
2105.HK Laekna, Inc.
10.840
-8.75%
688428.SS InnoCare Pharma Limited
13.39
-1.76%
2487.HK Cutia Therapeutics
7.010
-1.27%
3681.HK SinoMab BioScience Limited
1.050
-5.41%
9966.HK Alphamab Oncology
3.410
-7.59%
2162.HK Keymed Biosciences Inc.
34.550
-8.84%
6628.HK Transcenta Holding Limited
0.610
0.00%